-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A recent study published in the authoritative journal of rheumatology J Rheumatol compared the potential risk factors of psoriatic arthritis (PsA), psoriasis, rheumatoid arthritis (RA) and ankylosing spondylitis (AS)
.
.
Rheumatoid arthritis
Research using the health improvement network from 1994 to 2015 Jian data were 4 Xiang parallel case-control study
.
Use the disease code to find patients with PsA, psoriasis, RA, or AS, and pair them with controls that match age, gender, and year of treatment .
Research using the health improvement network from 1994 to 2015 Jian data were 4 Xiang parallel case-control study
Into PsA (N = 7,594), psoriasis (N = 111,375), RA ( N = 28,341) and AS (N = 3,253) patients, respectively, and with 75930,1113345,282226 and 3 253 0 matched controls
.
The median age at diagnosis was 48 years (IQR 38-59), 41 years (31-54), 43 years (31-54), and 60 years(48-71)
Into PsA (N = 7,594), psoriasis (N = 111,375), RA ( N = 28,341) and AS (N = 3,253) patients, respectively, and with 75930,1113345,282226 and 3 253 0 matched controls
Risk factors for four diseases
Risk factors for four diseases Risk factors for four diseasesThus, this study identified the risk factors of PsA, psoriasis, RA and AS .
The use of statins was negatively correlated with these 4 diseases .
Thus, this study identified the risk factors of PsA, psoriasis, RA and AS .
The use of statins was negatively correlated with these 4 diseases .
Original source:
Original source: Original source:Elana Meer.
Risk factors for diagnosis of psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis: A set of parallel case-control studies.
J Rheumatol.
Elana Meer.
Leave a message here
